We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OXIG Oxford Instruments Plc

-25.00 (-0.95%)
21 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Oxford Instruments Plc LSE:OXIG London Ordinary Share GB0006650450 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -25.00 -0.95% 2,615.00 2,635.00 2,645.00 2,655.00 2,585.00 2,585.00 435,532 16:35:26
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Lab Analytical Instruments 444.7M 58.6M 1.0126 26.02 1.52B
Oxford Instruments Plc is listed in the Lab Analytical Instruments sector of the London Stock Exchange with ticker OXIG. The last closing price for Oxford Instruments was 2,640p. Over the last year, Oxford Instruments shares have traded in a share price range of 1,634.00p to 2,850.00p.

Oxford Instruments currently has 57,873,131 shares in issue. The market capitalisation of Oxford Instruments is £1.52 billion. Oxford Instruments has a price to earnings ratio (PE ratio) of 26.02.

Oxford Instruments Share Discussion Threads

Showing 601 to 623 of 900 messages
Chat Pages: 36  35  34  33  32  31  30  29  28  27  26  25  Older
15 Jul 15 Investec Hold 906.50 1,100.00 950.00 Reiterates
09 Jul 15 Goldman Sachs Buy 906.50 900.00 900.00 Reiterates
02 Jul 15 Investec Hold 906.50 1,100.00 1,100.00 Reiterates
18 Jun 15 Barclays Capital Overweight 906.50 - 1,000.00 Retains
17 Jun 15 JP Morgan Cazenove Overweight 906.50 - - Reiterates
10 Jun 15 Liberum Capital Hold 906.50 - 930.00 Reiterates
10 Jun 15 Beaufort Securities Hold 906.50 - - Downgrades
10 Jun 15 JP Morgan Cazenove Overweight 906.50 1,200.00 1,200.00 Reiterates

wad collector
"OXFORD INSTRUMENTS PLC - Director/PDMR Shareholding

PR Newswire

London, June 15


Announcement to the London Stock Exchange

On 15 June 2015 the Company’s Executive Directors were granted nil cost option awards over ordinary shares of 5 pence each under the Oxford Instruments plc Performance Share Plan (the "PSP") as noted below:
Executive Director Number of shares under award
Jonathan Flint 67,631
Kevin Boyd 45,087

Subject to the terms of the PSP, the awards will ordinarily vest and become exercisable as from the third anniversary of the grant of the awards subject to the grantee’s continued service and to the extent to which earnings per share growth and relative total shareholder return performance criteria are met over a measurement period comprising three financial years of the Company.

Once exercisable, an award shall ordinarily remain exercisable until the eve of the tenth anniversary of the grant date of the awards.

No consideration was paid for the grant of the awards and no consideration is due on the vesting and/or exercise of the awards.

On the same date, Jonathan Flint’s wife and Company employee, Claire Flint, was granted options under the Oxford Instruments Executive Share Option Scheme over 20,350 ordinary shares of 5 pence at an option price of £10.28.

The Company was notified of the above transactions on 15 June 2015."

Does this mean the directors get this huge number of shares for nothing? What does it depend on?

Sharp rise this morning - has the nadir passed?
wad collector
Probably a good entry point. As you say not great figures -not disastrous either.
If Andor going well some other bits must be slipping.

Results worse than market expected but I think an overreaction so bought back at 967p.

09 June 2015

Release Date: 7am Tuesday 9 June 2015

Oxford Instruments plc

Announcement of Preliminary Results for the year to 31 March 2015

Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today announces its Preliminary Results for the year to 31 March 2015.


-- Orders grew by 13.0% to GBP386.6 million (2014: GBP342.2 million)
-- Revenue grew by 7.1% to GBP385.5 million (2014: GBP360.1 million)
-- On an Organic Constant Currency basis, Orders flat on prior year and Revenues declined by 5.4%

-- Adjusted profit before tax* of GBP35.6 million (2014: GBP47.1 million), reflecting macro headwinds in Japan and Russia, and weaker trading than expected in Industrial Analysis

-- Adjusted EPS* of 48.2p (2014: 67.7p)
-- Andor Technology acquisition has integrated well and is performing strongly
-- Cost reduction programme accelerated and delivering greater than planned savings
-- Investment in future organic growth: R&D spend increased to GBP35.2 million (2014: GBP27.9 million)

-- Proactive portfolio management to deliver long-term shareholder value: acquisition of MIR; joint venture to combine Oxford Instruments' Omicron business with Scienta Scientific AB

-- Proposed final dividend of 9.30 pence (2014: 9.04 pence), giving a total dividend for the year of 13.0 pence (2014: 12.4 pence)

*Adjusted numbers are stated to give a better understanding of the underlying business performance. Details of adjusting items can be found in Note 1.

Jonathan Flint, Chief Executive of Oxford Instruments plc, said:

"Overall, we have had a challenging year. We expect a return to organic growth in the coming year, with potential for margin improvement in the medium term. This reflects our swift and decisive action to improve our business, and our confidence that nanotechnology continues to drive long term demand for our high technology tools. Our strategy remains to grow our core markets of physical and materials science, and expand into life sciences."


wad collector
I do like these spikey movements in the share price combined with a narrow spread of 0.3% , tempting to trade on them...sold a third at 1080.
wad collector
From Beaufort

Oxford Instruments (LON:OXIG) – Buy

On Friday, Oxford Instruments announced the acquisition of Medical Imaging Resources (MIR), founded in 1990 and specializing in building, leasing and servicing of mobile medical imaging labs. The consideration comprises £6.8m on deal completion and a further £6.6m earn-out payable after one year. MIR has approximately £2.0m net debt at completion. MIR’s sales for the year 2014 stood at £10.8m and the pre-tax profit was £1.8m with gross assets worth £6.1m. MIR leases its mobile labs to the customers across the US and also services them. These labs are built in MIR’s factory, with Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) systems from Siemens, GE, Philips and Toshiba.

Our view: The acquisition of MIR bodes well for the future prospects of Oxford Instruments. The acquired business would be integrated into the company’s OIHealthcare division, thereby improving the company’s purchasing power and offering synergies in sections where there is duplication in operations. Both the companies serve General Electric MRI and CT machines in the US. Moreover, MRI has several other customers, for its mobile labs across the US that need to conduct CT and MRI trials but do not have additional infrastructure for the same. Oxford Instruments already enjoys a considerable brand equity and distribution network with an ever expanding network for its products. Thus, given its continued efforts to enhance operational efficiencies along with strategic acquisitions give the company a good upside potential. We retain a Buy rating for the stock.

wad collector
Very weird.
small crow
Similar pattern today ; odd .
wad collector
Something strange happened at the close today having meandered around 970 all day - sharp rise to about 1060 and one apparent trade of 25,000 shares at 1037.
wad collector
Trading update 2 weeks ago was in-line. Today's American shopping trip seems to be well received by the market as £10 beckons...

Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today announces the acquisition of Medical Imaging Resources, Inc. (MIR).

wad collector
Gone a bit quiet here Billy.

Sp recovering slowly , though I suspect it will be a long time until we see £15 again. I can wait.

wad collector
Billy Liar ( Amazed that is not your real name) I think you have called it incorrectly! £4 ? I think not.
wad collector
Goldman Sachs 'buy' rating £9 target


Perhaps he knows something about OXIGs listing that we don't...

Looking at the 10 yr share price graph above it is remarkable how volatile this has been.

wad collector
Sounds like oliversanvil is posting on the wrong board. He talks about all the investors on AIM which has nothing to with OXIG
alter ego
My query re action group was meant for OliversAnvil. I couldn't follow his post either.
My post was about 'trousering' -the post above I have no knowledge of.In fact I don't quite understand it!!
What annoys me (as a long term shareholder) is that while the board have, as you say, been trousering a large amount of cash, the shareholders have rec'd damn all in terms of dividends. Increases in share price can be here today and, as we have found, gone tomorrow while divs. are in the bank and can be spent.

Tell me more about the shareholders'action group; hadn't heard about it. Any link?

9 Feb'15 - 18:44 - 10061 of 10061 0 0 edit

Indeed i have joined the shareholders' action group. Company engineering administration by a suspect pattern that must be investigated by the law. Of course BLATANTLY the Bods are manoeuvring or are being manoeuvred by (? ) ( maybe who has the train set? ) thinking they are ahead of the law! The wishy washy legal loopholes have to be filled,and i believe a precedent will be set this time once and for ALL investors on the Aim

I did some background checks this morning -but couldn't be bothered posting. Seems like the main people on the board have been in situ for years trousering large amounts of cash whilst the share price has tanked. OK so that's recent -but this company looks like its in need of a shake up.I shall see who the main shareholders are and give it some thought. Looks like this was on a Renishaw,Spirax, Rotork type high rating and then crashed on disappointing news,
The ceo has a MBA from Southampton University -time it was put into action!!

I can't say I've ever thought much of the Chairman who appears to be somewhat overpaid.
without management changes the share price will drop further in my view. No support whatsoever. Very poor all round.The Chairman must step up to the plate here.
Chat Pages: 36  35  34  33  32  31  30  29  28  27  26  25  Older

Your Recent History

Delayed Upgrade Clock